IPO / listing 📈 Stocks 🌍 United States

Oura Targets $14.1 Billion Valuation in $2.2 Billion IPO

Oura eyes a $14.1 billion valuation as it prepares to list on the Nasdaq, backed by strong growth metrics and significant interest from institutional investors including Eli Lilly.

🕐 1 min read

2 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 1 Neutral. Strongest signal: OURA ↑ 7/10 (60% confidence).

📊 Affected Assets (2)

OURA
Bullish 🤖 60%
📅 Short-term 🌍 US · Explicit

Oura's IPO is priced at $40-44 per share, with strong revenue growth of 74% and interest from Eli Lilly and Dragoneer, indicating bullish sentiment.

LLY
Neutral 🤖 55%
📅 Short-term 🌍 US · Explicit

Eli Lilly's interest in buying up to $100 million of Oura shares is a minor strategic investment, unlikely to significantly affect Eli Lilly's stock.

🎯 Key Takeaways

  • Oura plans to sell 50 million shares at a price range of $40 to $44 per share.
  • Revenue grew 74% year-over-year to $1.21 billion for the nine months ending June 30.
  • Eli Lilly and Dragoneer have signaled interest in purchasing $100 million and $300 million in shares, respectively.

📝 Executive Summary

Finnish smart ring maker Oura plans to raise up to $2.2 billion in an IPO priced between $40 and $44 per share. The company reported a 74% revenue surge to $1.21 billion, attracting strategic interest from Eli Lilly and Dragoneer.

❓ FAQ

What is the expected valuation for Oura's IPO?

Oura is targeting a valuation of up to $14.1 billion based on the top end of its $40-$44 share price range.

How many smart rings has Oura sold recently?

Oura sold approximately 3.6 million smart rings over the past year.